Procter & Gamble Health Limited announces First Quarter results

Procter & Gamble Health Limited announced its financial results for the quarter ended September 30, 2021. The company has recorded a strong performance with sales of ₹ 267.8 crores, up 4% vs a year ago. The Profit After Tax (PAT) was ₹ 55.4 crores against ₹ 59.3 crores a year ago.

Milind Thatte, Managing Director, Procter & Gamble Health Limited said, "We delivered a strong performance in our first quarter of fiscal 2022 focused on executing our strategies of offering superior brands, driving productivity, increasing reach, and improving awareness. With the country gradually easing restrictions further due to improved vaccination coverage, we will continue our strategy to leverage technology and deliver constructive disruption to better serve our consumers and customers who count on our brands and the benefits they provide."

While the pandemic remains, so does our commitment to step up as a #forceforgood and a #forceforgrowth guidedour three core principles; protecting the health and safety of our employees and partners, ensuring uninterrupted supplies of our quality and affordable products, and supporting communities and relief efforts through our flagship CSR program 'SEHAT' (meaning Health)," he further added.

Shares of Procter & Gamble Health Limited was last trading in BSE at Rs. 5401.30 as compared to the previous close of Rs. 5404.00. The total number of shares traded during the day was 609 in over 319 trades.

The stock hit an intraday high of Rs. 5450.00 and intraday low of 5361.00. The net turnover during the day was Rs. 3290125.00.

Source : Equity Bulls

Keywords

ProcterandGambleHealthLimited INE199A01012 PGHL Pharmaceuticals Q1FY22 ResultUpdate